Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients

Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients

Abstract Background Immunosenescence biomarkers and peripheral blood parameters are evaluated separately as possible predictive markers of immunotherapy. Here, we illustrate the use of a causal inference model to identify predictive biomarkers of CIMAvaxEGF success in the treatment of Non–Small Cell...

Full description

Bibliographic Details
Main Authors: Patricia Lorenzo-Luaces, Lizet Sanchez, Danay Saavedra, Tania Crombet, Wim Van der Elst, Ariel Alonso, Geert Molenberghs, Agustin Lage
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Cancer
Subjects:
CIMAvaxEGF
Predictive biomarkers
Non-small-cell lung cancer
Causal inference
Online Access:http://link.springer.com/article/10.1186/s12885-020-07284-4

Internet

http://link.springer.com/article/10.1186/s12885-020-07284-4

Similar Items